Overview: Adenovirus Antigen Rapid TestIntroduction: The Adenovirus Antigen Rapid Test is a diagnostic tool designed to detect adenovirus antigens in nasopharyngeal swabs, stool, or saliva samples, facilitating the screening of adenovirus infections. Adenoviruses, a group of common viruses, cause a wide range of illnesses including respiratory infections, conjunctivitis, and gastroenteritis, presenting with symptoms such as cough, sore throat, diarrhea, and severe complications like pneumonia or encephalitis if untreated, particularly in immunocompromised individuals or young children. Per the 2023 Centers for Disease Control and Prevention guidelines, the test employs immunochromatographic technology, delivering results within 15-20 minutes with high sensitivity and specificity, making it a valuable tool for rapid diagnosis in outpatient and emergency settings. This rapid diagnostic falls under virology and targets individuals with respiratory or gastrointestinal symptoms, addressing the challenge of distinguishing adenovirus from other viral pathogens to guide appropriate supportive care and infection control measures. With morbidity rates elevated due to outbreaks in closed settings like schools, the test supports public health efforts by enabling early identification, isolation of cases, and prevention of transmission through hygiene education. Its multi-sample capability enhances its utility in diverse clinical presentations.Other Names: Adenovirus Rapid Test.FDA Status: FDA approved, CLIA certified for virology, compliant with 2025 standards.Historical Milestone: Introduced in the 2000s by Quidel, this test advanced adenovirus detection, providing a rapid alternative to viral culture.Purpose: The test screens for adenovirus antigens to guide infection diagnosis, assess disease severity, and inform treatment and prevention strategies.Test Parameters: Presence of Adenovirus Antigen, detected with high specificity to indicate active infection, typically detectable during the acute phase of illness, peaking within 3-7 days.Pretest Condition: No fasting required; patients should avoid food or drink for 30 minutes prior to collection to ensure sample integrity, and they should report respiratory symptoms, diarrhea, or recent exposure to ill contacts.Specimen: Nasopharyngeal Swab 1-2 swabs, Stool 5-10 gm, Saliva 1-2 mL, collected using sterile swabs/transport medium or containers, transported within 24 hours to maintain sample viability.Sample Stability at Room Temperature: 24 hours with proper handling in a cool environment to preserve antigen integrity, ensuring reliable test performance.Sample Stability at Refrigeration: 48 hours at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.Sample Stability at Frozen: Not recommended, as freezing may denature antigens, increasing the risk of false negatives and compromising diagnostic accuracy.Medical History: Patients should provide details on respiratory symptoms, diarrhea, conjunctivitis, or prior adenovirus infections, as well as any immunosuppressive conditions or recent outbreaks.Consent: Written informed consent is required, detailing the test's purpose, potential risks of untreated infection including pneumonia, benefits of early detection, and minimal discomfort from sample collection.Procedural Considerations: The test utilizes an immunochromatographic cassette requiring trained personnel to ensure sterile technique, avoid contamination, and interpret results within 15-20 minutes using provided positive and negative controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols, and store test kits according to manufacturer specifications to ensure reliability.Factors Affecting Result Accuracy: Delays beyond 24 hours, improper storage conditions, cross-contamination with other samples, or late-stage infection after antigen clearance can affect results. Correlation with PCR or viral culture is recommended to confirm findings.Clinical Significance: A positive result indicates adenovirus infection, necessitating supportive care such as hydration or isolation. A negative result may require follow-up testing if symptoms persist, especially if sampled outside the antigen peak window.Specialist Consultation: Infectious disease specialists or pediatricians should be consulted for case management, treatment planning, and coordination with public health authorities.Additional Supporting Tests: Adenovirus PCR, viral culture, or serology for confirmation.Test Limitations: The test may produce false negatives in late infection or false positives due to cross-reactivity, requiring a comprehensive diagnostic approach that includes molecular methods and clinical correlation.References: CDC Guidelines 2023, Journal of Clinical Virology 2024, Pediatrics 2025.